German Mini Glatt&Midi Glatt fluidized bed-Fornitore globale

Room 2405, Block D, Range Rover Mansion, 588 Gangcheng East Street, Laishan District, Yantai City, Shandong Province

MINI Glatt&MIDI Glatt fluidized bed in Germany

In recent years, with the expiration of patents for original drugs, the generic drug market has become increasingly lively. Glatt's fluidized bed is widely used by pharmaceutical companies in 128 countries around the world and has become a standard in the industry. Glatt is currently the world's number one fluidized bed brand. Glatt company constantly strives for excellence in its products every year. In addition to adding more user-friendly operating functions and HMI interfaces, it has also developed research and development specific models to serve researchers. The Mini/Medi models are very suitable for laboratory and preclinical product development and are favored by universities, research institutes, CRO/CMO, and pharmaceutical companies' R&D departments around the world.

High quality fluidized bed system

Can be used for drying, mixing, granulation, coagulation, powder coating, granule coating, and pellet coating.

Designed for experimental small batch fluidization, especially suitable for research and development departments of universities, CRO/CMO, and pharmaceutical companies.

Main characteristics

1. Using Glatt's patented technology, metal filter rods are used instead of filter screens for longer service life and easier cleaning.

2. It can complete the functions of drying, top spray granulation, and bottom spray coating.

3. One machine for multiple uses, one set of main unit, switch between Mini/Medi/Micro Kit pot body for use.

Main technical parameters:

Grate Mini Batch: 25g to 375g/Batch

Grat Microkit Batch: 2.5g to 10g/Batch

Grat Midi Batch: 500g to 1350g/Batch

Brand advantage

GLATT from Germany is the inventor of fluidized bed technology and currently the world's number one fluidized bed brand, enjoying a high reputation worldwide. Most of the Fortune Global 500 multinational pharmaceutical companies are equipped with GLATT experimental and production fluidized beds. GLATT has established large research and pilot study centers in both Europe and the United States, and has established close relationships with the FDA and the European Medicines Agency, which reduces the difficulty for domestic pharmaceutical customers to enter the US and European markets or engage in cooperation with foreign countries in the future.

GLATT entered China in 1980 and sold its first equipment, making it the most dominant fluidized bed supplier among imported brands.

Domestic users

GLATT has a large number of high-quality users in China, which reduces the difficulty for customers to cooperate with numerous research institutions or large pharmaceutical companies in the future. At the same time, there are many varieties of GLATT equipment launched in China, including many well-known brands such as Xinkangtaike, Tainuo, Jinsherkang, Xingling Granules, 21 Jinweita, Liushen Wan, Glibizine sustained-release capsules, Tansuluo hydrochloride sustained-release capsules, 5-mononitrate isosorbide sustained-release capsules, acetaminophen oral disintegrating tablets, irbesartan tablets, amlodipine tablets, and so on.

Technical support

GLATT has established a technical service center in Shanghai, where its research personnel have rich experience in the pharmaceutical industry. In addition, GLATT's more than 70 years of experience in the fluidized bed field can provide customers with various technical support from small-scale research and development to mass production. The center has collaborated with domestic clients to develop over 300 varieties of microspheres and dozens of powder coated varieties, many of which have already been launched for sale. Famous cases include Hangzhou Minsheng, Shanghai Shiguibao, Zhongmei Square, Jiangsu Hengrui, Beijing Saike, Zhejiang Kangenbei, Shanghai Xingling, Zhejiang Huahai, Shanghai Aidifa, Dalian Pfizer, Shanghai Roche, Novartis, Beijing Sihuan, Beijing Anwante, Beijing Fresenius, Fujian Xing'an, Shanghai Leyunshang, Yangtze River Pharmaceutical, Dalian Meiluo, Shandong Lu'an, Tianjin Zhongxin, Tianjin Shiweiya, Wuxi Rodia, etc. In addition, GLATT Technical Service Center has extensive experience in scaling up from small-scale trials (30-300 grams) to production models weighing 100 kilograms per batch.

Technical advantages

GLATT's experimental fluidized bed has multiple world invention patents and has an absolute technological advantage over other competitors. For example, MINI/MIDI GLATT uses the most advanced metal filters, which can achieve a filtering effect of less than 1um. At the same time, the surface is smoothed by special processes to ensure minimal material adhesion and residue.

The spray gun of MINI/MIDI GLATT has a number of invention patents, which can ensure the most perfect columnar spray effect while avoiding the occurrence of adhesion, blockage and residue.

GLATT's headquarters in Germany has a dedicated wind tunnel laboratory that conducts extensive experiments on how to achieve the optimal fluidization state in line with the pharmaceutical industry and has reliable experimental data as a reference. On this basis, GLATT has developed a chassis aerodynamic distribution plate that matches the pharmaceutical industry, ensuring that GLATT's fluidized bed has the best aerodynamic effect.

In terms of material and processing technology, GLATT selects different 316L series stainless steel to make different accessories according to different process requirements, in order to achieve various mechanical motion effects. Multiple polishing and special process treatments have been carried out on the inner surface of the cavity in contact with the material, which has the effect of reducing static electricity and friction.

MINI/MIDI GLATT is a device designed specifically for research and development, with the world's smallest batch production capacity, conducting research experiments in three batch ranges from 2.5g-10g to 25g-375g to 500g-1350g. This is something that other competitors do not possess. Due to the use of the same design concept and control components as the production equipment, this device greatly reduces the difficulty of future process amplification.

Process connection

At present, most domestic fluidized bed brands are imitating Glatt equipment, and the principle is basically the same. Therefore, there is no process barrier for scaling up products developed using Glatt experimental equipment to domestically produced fluidized beds. GLATT Shanghai laboratory has rich experience in how to connect with domestic production equipment and has a large number of cases for reference, which can assist and cooperate with customers in future large-scale production.

MINI pot body is suitable for 25-375 g (2.5g-10g requires a trace material plugin)

MIDI pot suitable for 500-1350g